The TGA has published an update to the TGA list of COBs on their webpage which outlines criteria and overview of the COB report-based process. 

The TGA can use evaluation reports from comparable overseas bodies (COBs) to evaluate safety and/or quality and/or efficacy for the following pre-market applications:

 - registered complementary medicines

 - assessed listed medicines

 - substances for use as ingredients in listed medicines.

Today’s technical alert provides more information, including a comparison of the 2019 list and the newly published 2022 list of COBs which outlines any changes or additions.